Recent experiences in scaling up HPV vaccination and cervical screening in low-and middle-income cou

来源 :The 6th Biennial Conference of Asia Oceania Research Organis | 被引量 : 0次 | 上传用户:LISA19861011
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
The knowledge that cervical neoplasia are caused by persistent infection with one of the high-risk types of human papilloma virus types and around 70% cervical cancers are caused by HPV 16 or HPV 18 persistent infections had led to HPV vaccination as an important public health strategy to prevent cervical cancer.
其他文献
Background:Most women in urban populations in China do not have access to cervical screening and the role of HPV in screening low resource urban women has not been clarified.Objectives: To quantify ef
Colposcopy plays a central role in cervical cancer prevention.With the increasing knowledge about etiology and pathogenesis of cervical disease, the role of colposcopy is far more than to identify the
会议
After 10 years since the first clinical trial of the HPV vaccines, new long-term data is now available particularly in the areas of long-term vaccine effectiveness and safety.
会议
Australia and New Zealand (NZ) both have successful organised national cervical screening programs, both established in 1991, which in both countries have resulted in significant reductions in cervica
会议
Whether in clinical trials, prospective cohort studies, or routine screening programs, too many individuals are categorized as "lost to follow-up".How can we prevent the "loss" of these people?
会议
Using science to inform decision making ensures that policies and practices used in the prevention, detection, and treatment of diseases are based on data, principles, and findings.
会议
Objective: To develop and implement a community based model for cervical cancer prevention that allows the communities to manage the screening and the healthcare system to focus resources on evaluatio
会议
El Salvador has one of the worlds highest cervical cancer incidence and mortality rates.To improve cervical cancer screening, the Ministry of Health (MOH), in cooperation with Basic Health Internation
会议
Although HPV vaccination will likely be the ultimate cervical cancer prevention strategy,given its effectiveness, the worldwide familiarity and acceptance of vaccination as a preventive strategy, and
会议
Arbor Vita Corporation, in collaboration with PATH and CICAMS, developed the OncoE6TM Cervical Test ("E6 Test") for settings where ease of test use, short time from sample collection to result, and a
会议